Suppr超能文献

1型糖尿病患者肾内阻力指数及不同肾脏生物标志物对早期诊断糖尿病肾病价值的随访研究

Follow Up of Value of the Intrarenal Resistivity Indices and Different Renal Biomarkers for Early Identification of Diabetic Nephropathy in Type 1 Diabetic Patients.

作者信息

Dayem Soha Abd El, Bohy Abo El Magd El, Hamed Mona, Ahmed Solaf

机构信息

Pediatrics Department, National Research Centre, Cairo, Egypt.

Radiology Department, Cairo University, Cairo, Egypt.

出版信息

Open Access Maced J Med Sci. 2017 Mar 20;5(2):188-192. doi: 10.3889/oamjms.2017.034. eCollection 2017 Apr 15.

Abstract

AIM

To evaluate intrarenal resistivity index (RI) and different biomarkers of diabetic nephropathy (DN) with clinical signs of DN and its progression over time as early detection of DN.

PATIENTS AND METHODS

This longitudinal study included 48 type 1 diabetic patients who were studied at baseline and after three years. A blood sample was taken for assessment of glycosylated haemoglobin (HbA1), lipid profile and a urine sample was taken for assessment of albumin/creatinine ratio, Neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid binding protein (L-FABP) and kidney injury molecule-1 (Kim-1) at baseline and after three years. Forty diabetic patients did renal Doppler at baseline & after three years.

RESULTS

HbA1, waist/hip ratio, albumin/creatinine ratio, lipid profile, NGAL, KIM-1, L-FABP and resistivity index (RI) were significantly increased in follow-up. Twenty patients (41.7%) showed progression to albuminuria. RI showed a significant increase in follow-up study. ROC curve showed that RI and NGAL had the highest sensitivity (100%), followed by L-FABP (90%) and lastly KIM-1 (63.6%) in the prediction of DN.

CONCLUSION

High RI, NGAL, KIM-1 & L-FABP can be considered as early markers of diabetic nephropathy in type 1 diabetics and are associated with its progression over time, independent of albuminuria.

摘要

目的

评估肾内电阻抗指数(RI)及糖尿病肾病(DN)的不同生物标志物,以及DN的临床体征及其随时间的进展情况,以实现DN的早期检测。

患者与方法

这项纵向研究纳入了48例1型糖尿病患者,在基线期和三年后进行研究。在基线期和三年后采集血样,用于评估糖化血红蛋白(HbA1)、血脂谱;采集尿样,用于评估白蛋白/肌酐比值、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、肝型脂肪酸结合蛋白(L-FABP)和肾损伤分子-1(Kim-1)。40例糖尿病患者在基线期和三年后进行了肾脏多普勒检查。

结果

随访期间,HbA1、腰臀比、白蛋白/肌酐比值、血脂谱、NGAL、Kim-1、L-FABP和电阻抗指数(RI)显著升高。20例患者(41.7%)出现蛋白尿进展。随访研究显示RI显著升高。ROC曲线显示,在预测DN方面,RI和NGAL的敏感性最高(100%),其次是L-FABP(90%),最后是Kim-1(63.6%)。

结论

高RI、NGAL、Kim-1和L-FABP可被视为1型糖尿病患者糖尿病肾病的早期标志物,且与病情随时间的进展相关,独立于蛋白尿。

相似文献

6

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验